Tls Advisors LLC Ovid Therapeutics Inc. Transaction History
Tls Advisors LLC
- $32 Million
- Q2 2025
A detailed history of Tls Advisors LLC transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Tls Advisors LLC holds 680,967 shares of OVID stock, worth $374,531. This represents 0.7% of its overall portfolio holdings.
Number of Shares
680,967
Previous 680,967
-0.0%
Holding current value
$374,531
Previous $213,000
5.63%
% of portfolio
0.7%
Previous 0.48%
Shares
6 transactions
Others Institutions Holding OVID
# of Institutions
71Shares Held
32.7MCall Options Held
15.6KPut Options Held
0-
Black Rock Inc. New York, NY3.99MShares$2.2 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$2.12 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.64MShares$1.45 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY2.23MShares$1.23 Million0.35% of portfolio
-
Acadian Asset Management LLC Boston, MA2.11MShares$1.16 Million0.0% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $38.7M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...